TrialThe Journal of urology2011

A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range.

William J Catalona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.